Applicants: Universidade de Vigo
The human monoclonal antibody recognizing the CD69 human molecule comprises the product hAIM-29 formed from the hybridoma H69. Also claimed is a process using the antibody in therapy. The process forms H69 by fusion of cells of NSO murine myeloma with transgenic rat spleen cells immunized with rat cells immunized with CD69.
More information: Oficina Española de Patentes y Marcas
Associated research lines: Immunotherapy.